Full text
PDF

















Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERLINER R. W., HILTON J. G., YU T. F., KENNEDY T. J. The renal mechanism for urate excretion in man. J Clin Invest. 1950 Apr;29(4):396–401. doi: 10.1172/JCI102271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BERLINER R. W. The kidney. Annu Rev Physiol. 1954;16:269–304. doi: 10.1146/annurev.ph.16.030154.001413. [DOI] [PubMed] [Google Scholar]
- BOGER W. P., STRICKLAND S. C., BAYNE G. M., GYLFE J. Probenecid and salicylates: the question of interaction in terms of penicillin excretion. J Lab Clin Med. 1955 Mar;45(3):478–484. [PubMed] [Google Scholar]
- BURNS J. J., YU T. F., BERGER L., GUTMAN A. B. Zoxazolamine: physiological disposition, uricosuric properties. Am J Med. 1958 Sep;25(3):401–408. doi: 10.1016/0002-9343(58)90079-2. [DOI] [PubMed] [Google Scholar]
- BURNS J. J., YU T. F., RITTERBAND A., PEREL J. M., GUTMAN A. B., BRODIE B. B. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed] [Google Scholar]
- CRONE C., LASSEN U. V. The effect of salicylic acid and acetylsalicylic acid on uric acid excretion and plasma uric acid concentration in the normal human subject. Acta Pharmacol Toxicol (Copenh) 1955;11(4):355–361. doi: 10.1111/j.1600-0773.1955.tb03270.x. [DOI] [PubMed] [Google Scholar]
- GOLDTHWAIT J. C., BUTLER C. F., STILLMAN J. S. The diagnosis of gout; significance of an elevated serum uric acid value. N Engl J Med. 1958 Dec 4;259(23):1095–1099. doi: 10.1056/NEJM195812042592301. [DOI] [PubMed] [Google Scholar]
- GUTMAN A. B. Some recent advances in the study of uric acid metabolism and gout. Bull N Y Acad Med. 1951 Mar;27(3):144–164. [PMC free article] [PubMed] [Google Scholar]
- GUTMAN A. B., YU T. F. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians. 1951;64:279–288. [PubMed] [Google Scholar]
- GUTMAN A. B., YU T. F. Gout, a derangement of purine metabolism. Adv Intern Med. 1952;5:227–302. [PubMed] [Google Scholar]
- GUTMAN A. B., YU T. F. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med. 1957 Oct;23(4):600–622. doi: 10.1016/0002-9343(57)90231-0. [DOI] [PubMed] [Google Scholar]
- GUTMAN A. B., YU T. F. Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. Bull N Y Acad Med. 1958 May;34(5):287–296. [PMC free article] [PubMed] [Google Scholar]
- GUTMAN A., YU T. F., SIROTA J. H. A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. J Clin Invest. 1955 May;34(5):711–721. doi: 10.1172/JCI103124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOFFMAN W. S., NOBE C. The influence of urinary pH on the renal excretion of salicyl derivatives during aspirin therapy. J Lab Clin Med. 1950 Feb;35(2):237–248. [PubMed] [Google Scholar]
- KERSLEY G. D., COOK E. R., TOVEY D. C. Value of uricosuric agents and in particular of G. 28 315 in gout. Ann Rheum Dis. 1958 Sep;17(3):326–333. doi: 10.1136/ard.17.3.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAMBIOTTE C., BLANCHARD J., GRAFF S., GRAFF A. Thiosulphate clearance in pregnancy. J Clin Invest. 1950 Sep;29(9):1207–1213. doi: 10.1172/JCI102358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MACPHERSON C. R., MILNE M. D., EVANS B. M. The excretion of salicylate. Br J Pharmacol Chemother. 1955 Dec;10(4):484–489. doi: 10.1111/j.1476-5381.1955.tb00109.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MARSON F. G. Sodium salicylate and probenecid in the treatment of chronic gout; assessment of their relative effects in lowering serum uric acid levels. Ann Rheum Dis. 1954 Sep;13(3):233–245. doi: 10.1136/ard.13.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILNE M. D., SCRIBNER B. H., CRAWFORD M. A. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med. 1958 May;24(5):709–729. doi: 10.1016/0002-9343(58)90376-0. [DOI] [PubMed] [Google Scholar]
- OGRYZLO M. A., HARRISON J. Evaluation of uricosuric agents in chronic gout. Ann Rheum Dis. 1957 Dec;16(4):425–437. doi: 10.1136/ard.16.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PASCALE L. R., DUBIN A., BRONSKY D., HOFFMAN W. S. Inhibition of the uricosuric action of benemid by salicylate. J Lab Clin Med. 1955 May;45(5):771–777. [PubMed] [Google Scholar]
- PASCALE L. R., DUBIN A., HOFFMAN W. S. Therapeutic value of probenecid (benemid) in gout. J Am Med Assoc. 1952 Jul 26;149(13):1188–1194. doi: 10.1001/jama.1952.02930300014004. [DOI] [PubMed] [Google Scholar]
- SALTERI F., CIRLA E., FASOLI A. Electromigration on filter paper of uric acid from serum and synovial fluid. Science. 1958 Jan 10;127(3289):85–86. doi: 10.1126/science.127.3289.85. [DOI] [PubMed] [Google Scholar]
- SCHACHTER D., MANIS J. G. Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. J Clin Invest. 1958 Jun;37(6):800–807. doi: 10.1172/JCI103667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith H. W., Finkelstein N., Aliminosa L., Crawford B., Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945 May;24(3):388–404. doi: 10.1172/JCI101618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YU T. F., BERGER L., STONE D. J., WOLF J., GUTMAN A. B. Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions. Proc Soc Exp Biol Med. 1957 Oct;96(1):264–267. doi: 10.3181/00379727-96-23450. [DOI] [PubMed] [Google Scholar]
- YU T. F., BURNS J. J., GUTMAN A. B. Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. Arthritis Rheum. 1958 Dec;1(6):532–543. doi: 10.1002/art.1780010606. [DOI] [PubMed] [Google Scholar]
- YU T. F., GUTMAN A. B. Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med. 1955 Nov;90(2):542–547. doi: 10.3181/00379727-90-22094. [DOI] [PubMed] [Google Scholar]
- YU T. F., PATON B. C., CHENKIN T., BURNS J. J., BRODIE B. B., GUTMAN A. B. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. J Clin Invest. 1956 Apr;35(4):374–385. doi: 10.1172/JCI103288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YU T. F., SIROTA J. H., BERGER L., HALPERN M., GUTMAN A. B. Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med. 1957 Dec;96(3):809–813. doi: 10.3181/00379727-96-23616. [DOI] [PubMed] [Google Scholar]
- YU T. F., SIROTA J. H., GUTMAN A. B. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836. [DOI] [PMC free article] [PubMed] [Google Scholar]